Human Malignant Gliomas Secrete a Factor that Increases Brain Capillary Permeability: Role in Peritumoural Brain Oedema

  • T. Ohnishi
  • T. Hayakawa
  • W. R. Shapiro
Part of the Acta Neurochirurgica book series (NEUROCHIRURGICA, volume 51)


The effect of conditioned media obtained from two human malignant gliomas and normal human glia on rat brain capillary permeability was investigated by measuring the entry of 14C-aminoisobutyric acid by a quantitative autoradiographic method. Conditioned media were concentrated 50-fold to create SUP-C. The SUP-C contained proteins with a molecular weight greater than 10 kD. The SUP-C from glioma cells markedly increased brain capillary permeability, whereas that from normal glial cells did not. The activity of capillary permeability factor in the SUP-C was significantly inhibited by pretreatment of animals with dexamethasone or BW755C (lipoxygenase inhibitor), but not with indomethacin. On the other hand, coincubation of glioma cells with dexamethasone produced SUP-C whose capillary permeability activity was about one and a half times greater than that without dexamethasone. These results indicate that human malignant glioma cells secrete a protein factor that increases brain capillary permeability. Glucocorticoids inhibit the effect of the factor by directly acting on capillary endothelial cells, possibly through the inhibition of phospholipase A2 activity, resulting in a decrease of lipoxygenase rather than cyclo-oxygenase products.


Conditioned Medium Glioma Cell Malignant Glioma Capillary Endothelial Cell Capillary Permeability 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Asch AS, Leung LLK, Shapiro JR et al (1986) Human brain glial cells synthesize thrombospondin. Proc Natl Acad Sci USA 83: 2904–2908PubMedCrossRefGoogle Scholar
  2. 2.
    Dvorak HF (1986) Tumours: wounds that do not heal. Similarities between tumour stroma generation and wound healing. N Engl J Med 315: 1650–1659PubMedCrossRefGoogle Scholar
  3. 3.
    Hiesiger EM, Voorhies RM, Basler GA et al (1986) Opening the blood-brain and blood-tumour barriers in experimental rat brain tumours: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Ann Neurol 19: 50–59PubMedCrossRefGoogle Scholar
  4. 4.
    Hirata F (1918) The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem 256: 7730–7733Google Scholar
  5. 5.
    Leenders KL, Beaney RP, Brooks DJ et al (1985) Dexamethasone treatment of brain tumour patients: effects on regional cerebral blood flow, blood volume, and oxygen utilization. Neurology 35: 1610–1616PubMedGoogle Scholar
  6. 6.
    Matsuoka Y, Hossman KA (1981) Corticosteroid therapy of experimental tumour oedema. Neurosurg Rev 4: 185–190PubMedCrossRefGoogle Scholar
  7. 7.
    Ohnishi T, Shapiro WR (1987) Vascular permeability factors produced by brain tumours: possible role in peritumoural brain oedema. J Neuro-Oncol 5: 179Google Scholar
  8. 8.
    Ohnishi T, Sher PB, Posner JB et al (1990) Increased capillary permeability in rat brain induced by factors secreted by cultured C6 glioma cells: role in peritumoural brain oedema. J NeuroOncol (in press)Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • T. Ohnishi
    • 3
  • T. Hayakawa
    • 1
  • W. R. Shapiro
    • 2
  1. 1.Department of NeurosurgeryOsaka University Medical SchoolOsakaJapan
  2. 2.Department of NeurologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Department of NeurosurgeryOsaka University Medical SchoolFukushima, Osaka 553Japan

Personalised recommendations